Therefore, although the assay of LppZ-specific IgA is not good enough on its own for clinical application, it can increase the sensitivities of ESAT-6 or CFP-10-specific IFN-γ release assays in TB and LTBI screening, suggesting the potential value of LppZ-specific IgA as an adjunctive screening biomarker. Here, CD79A is linked to tuberculosis.